Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 21
Summary
- Conditions
- Brain Cancer
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01892397
- Collaborators
- NovoCure Ltd.
- Columbia University
- University of Cincinnati
- University of Colorado, Denver
- University of Miami
- Cedars-Sinai Medical Center
- Investigators
- Principal Investigator: Thomas Kaley, MD Memorial Sloan Kettering Cancer Center
Get Well Soon